Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Thrombocytopenia 6Leukemia, Myeloid, Acute 6Leukemia 6Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 3Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Jacobs syndrome 2Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Hematologic Neoplasms 1Congenital Abnormalities 1Chemotherapy-induced Thrombocytopenia 1Bone Marrow Failure Disorders 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Cyclophosphamide 58Dexamethasone 50Rituximab 39Peripheral Blood Stem Cell Transplantation 29Paclitaxel 29Lenalidomide 28fludarabine phosphate 27Gemcitabine 26Etoposide 26Bortezomib 26Cytarabine 25Busulfan 24pembrolizumab 21Radiotherapy 21Bevacizumab 21Carboplatin 20Mycophenolic Acid 19Melphalan 19Cisplatin 19Filgrastim 18pomalidomide 17fludarabine 17Oxaliplatin 17Antilymphocyte Serum 17Cyclosporine 16Tacrolimus 15Methotrexate 15Whole-Body Irradiation 14Methylprednisolone 13Bendamustine Hydrochloride 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Recurrence × eltrombopag × Clear all
NCT01484314 2017-03-15

Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma

Dana-Farber Cancer Institute

Phase 2 Terminated
1 enrolled 1 chart
Classical hematologyPlasma cell

Multiple Myeloma, Recurrence, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡